← Evidence map

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026

Gemcitabine Intravesical System Plus Cetrelimab or Cetrelimab Alone as Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer: SunRISe-4 Primary Analysis and Biomarker Results.

Andrea Necchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2026
this paperpooled itcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 41337691